Patents Assigned to Fondation ELA
  • Pioglitazone for use in the treatment of adrenoleukodystrophy
    Patent number: 8865747
    Abstract: The present invention is directed to pioglitazone, or a pharmaceutically acceptable salt thereof, as well as a pharmaceutical composition comprising pioglitazone, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, for use in the treatment and/or prevention of an adrenoleukodystrophy.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: October 21, 2014
    Assignees: Fundació Institute D'Investigació Biomėdica de Bellvitge (IDIBELL), Fundació Institució Catalana de Recerca I Estudis Avançats (ICREA), Fondation ELA
    Inventor: Aurora Pujol Onofre